SironRX Therapeutics
VerifiedclosedSironRX is developing novel therapies that promote dermal wound repair and reduce scarring.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$14—20m (Dealroom.co estimates Aug 2011.)
Cleveland Ohio (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
$3.4m | Series A | ||
| Total Funding | 000k | ||